Dr. Glenn M. Giessel, MD

Dr. Giessel practices at Viemed in Lafayette, Louisiana.

Dr. Giessel's NPI, 1386677540, was assigned on July 9, 2006. Dr. Giessel graduated from Baylor College Of Medicine in 1978. Dr. Giessel holds Virginia license 0101031697.

Dr. Giessel's primary practice is Viemed, at 625 E Kaliste Saloom Rd, Lafayette, LA 70508 in Lafayette Parish. The practice phone is (337) 504-3802.

Dr. Giessel's primary practice is Viemed in Lafayette, Louisiana. The medical group on file is Pulmonary Associates of Richmond. Dmand AI also links Dr. Giessel to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Giessel practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Giessel's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Giessel is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Giessel's licenses on file in 2 states: Virginia and Texas.

Dmand AI lists acute sinusitis, asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, hypersomnia, pleural effusion and pneumonia among the conditions Dr. Giessel treats.

CMS data shows 1,705 Medicare services from Dr. Giessel across 8 procedure codes in 2024, for 304 Medicare patients. Medicare paid $50,694 for them. Every service was in an office.

CMS counts 304 Medicare patients who saw Dr. Giessel in 2024. The largest group is 75 to 84, with 127 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Giessel's median patient age at 67, with 46% women.

In 2024, Dr. Giessel wrote 2,599 Medicare Part D claims for 494 patients. 39% of them were for generic drugs. CMS names the drug for 2,366 of them, across 31 drugs with 11 or more claims each, at $972,262 in total drug cost. In 2023, CMS named 5,306 claims across 50 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Giessel for performance year 2024, reported as part of a group.

Dmand AI links 1 paper to Dr. Giessel in 2022.

Dmand AI links Dr. Giessel to 1 clinical trial. Conditions studied include Lung Neoplasms and Thoracic Neoplasms.

CMS Open Payments shows 1,039 general payments to Dr. Giessel from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 66% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $6,592. It also lists 20 research payments totaling $3,561 from 2016 to 2017.

Dmand AI lists 2 awards for Dr. Giessel, most recently CMS Stage 1 2012 in 2012.

Dr. Giessel graduated from Baylor College Of Medicine in 1978.

Dr. Giessel is in network with 12 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.